Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Legend Biotech Corp stock

Learn how to easily invest in Legend Biotech Corp stock.

Legend Biotech Corp is a biotechnology business based in the US. Legend Biotech Corp shares (LEGN) are listed on the NASDAQ and all prices are listed in US Dollars. Legend Biotech Corp employs 1,071 staff and has a trailing 12-month revenue of around $118.6 million.

How to buy shares in Legend Biotech Corp

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LEGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Legend Biotech Corp stock price (NASDAQ: LEGN)

Use our graph to track the performance of LEGN stocks over time.

Legend Biotech Corp shares at a glance

Information last updated 2022-09-27.
Latest market close$40.80
52-week range$30.76 - $58.00
50-day moving average $45.81
200-day moving average $43.39
Wall St. target price$66.86
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.37

Buy Legend Biotech Corp shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Legend Biotech Corp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Legend Biotech Corp price performance over time

Historical closes compared with the close of $40.8 from 2022-09-30

1 week (2022-09-23) 5.15%
1 month (2022-09-01) -12.76%
3 months (2022-07-01) -26.93%
6 months (2022-04-01) 4.35%
1 year (2021-10-01) -18.74%
2 years (2020-10-01) 31.57%
3 years (2019-09-27) N/A
5 years (2017-09-27) N/A

Legend Biotech Corp financials

Revenue TTM $118.6 million
Gross profit TTM $91.6 million
Return on assets TTM -27.65%
Return on equity TTM -107.41%
Profit margin -292.09%
Book value $2.83
Market capitalisation $6.5 billion

TTM: trailing 12 months

Legend Biotech Corp share dividends

We're not expecting Legend Biotech Corp to pay a dividend over the next 12 months.

Legend Biotech Corp share price volatility

Over the last 12 months, Legend Biotech Corp's shares have ranged in value from as little as $30.755 up to $58. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Legend Biotech Corp's is -0.6627. This would suggest that Legend Biotech Corp's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Legend Biotech Corp has bucked the trend.

Legend Biotech Corp overview

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel.

Frequently asked questions

What percentage of Legend Biotech Corp is owned by insiders or institutions?
Currently 1.349% of Legend Biotech Corp shares are held by insiders and 32.147% by institutions.
How many people work for Legend Biotech Corp?
Latest data suggests 1,071 work at Legend Biotech Corp.
When does the fiscal year end for Legend Biotech Corp?
Legend Biotech Corp's fiscal year ends in December.
Where is Legend Biotech Corp based?
Legend Biotech Corp's address is: 2101 Cottontail Lane, Somerset, NJ, United States, 08873
What is Legend Biotech Corp's ISIN number?
Legend Biotech Corp's international securities identification number is: US52490G1022

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site